All In Biotech

Free tool

FAERS Monitor: Breo Ellipta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204275 or its brand name (Breo Ellipta, Fluticasone Furoate, Vilanterol Trifenatate). Reports on generic versions are filed under their own applications.

Reports

36,211

Serious

15,062

42% of reports

Hospitalization

7,490

Death reported

1,485

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea6,235
  • drug ineffective4,089
  • asthma4,061
  • cough3,458
  • wheezing2,688
  • wrong technique in device usage process2,341
  • pneumonia2,247
  • product complaint1,882
  • product dose omission issue1,827
  • fatigue1,769
  • off label use1,587
  • therapeutic product effect incomplete1,553
  • malaise1,479
  • loss of personal independence in daily activities1,395
  • headache1,364

Reports by year received

View as table
YearReports
20102
20112
20126
201314
2014738
20151,546
20162,738
20173,448
20184,039
20194,379
20204,480
20213,696
20222,734
20232,424
20242,390
20252,136
20261,439

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,017,948 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product complaintSignal1,88246.544.477,657
wrong technique in device usage processSignal2,34130.629.463,771
wheezingSignal2,68827.526.565,769
asthmaSignal4,06121.621.077,361
loss of personal independence in daily activitiesSignal1,39517.316.520,892
therapeutic product effect incompleteSignal1,55312.912.316,783
coughSignal3,4587.27.018,608
dyspnoeaSignal6,2356.56.329,223
pneumoniaSignal2,2474.13.95,207
product dose omission issueSignal1,8273.63.53,498
malaise1,4792.01.9709
drug ineffective4,0891.81.81,559
fatigue1,7691.31.3142
headache1,3641.31.277
off label use1,5871.11.04

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.